Travere Therapeutics (TVTX) Change in Receivables (2014 - 2026)
Travere Therapeutics' Change in Receivables was -$6.64 million in Q2 2026, compared with $4.28 million a year earlier.
Travere Therapeutics (TVTX) Change in Receivables (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Travere Therapeutics' Change in Receivables was $16.92 million through Jun 30, 2026, up 19.1% year-over-year; for FY2025, it was $27.82 million, up 363.6% from FY2024.
- In earlier years, Change in Receivables was $6 million in FY2024 (-46.7%), $11.26 million in FY2023 (+962.6%), $1.06 million in FY2022 and -$853,000 in FY2021.
- Quarterly Change in Receivables has moved between -$27.82 million (Q4 2025) and $44.16 million (Q3 2025) over five years.
- Compared with a year earlier, Change in Receivables was higher in three of the last four quarters, with growth averaging 109.3%.
- The best year-over-year quarter for Change in Receivables over five years was Q1 2025 (growth of 365.7%); the worst was Q4 2024 (a decline of 75.1%).
- Per Business Quant data, TVTX's Change in Receivables in the three quarters before Q2 2026 was $7.23 million (Q1 2026), -$27.82 million (Q4 2025) and $44.16 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn | -6.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.64 Mn |
| Mar 31, 2026 | 7.23 Mn |
| Dec 31, 2025 | -27.82 Mn |
| Sep 30, 2025 | 44.16 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 731,000.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 7.97 Mn |
| Sep 30, 2023 | -785,000.00 |
| Jun 30, 2023 | -578,000.00 |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | -5.72 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | -1.24 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 1.48 Mn |
Travere Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();